Patents by Inventor Bryan Beattie

Bryan Beattie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Purified FabI polypeptides from
    Patent number: 7601526
    Abstract: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein derived from Fransicella tularensis comprising the amino acid sequence set forth in SEQ ID NO: 2. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
    Type: Grant
    Filed: December 28, 2006
    Date of Patent: October 13, 2009
    Assignee: Affinium Pharmaceuticals, Inc.
    Inventors: Judd M. Berman, Molly B. Schmid, Donald E. Awrey, Teresa Clarke, Bryan Beattie, Mandy Dorsey
  • Novel purified FabI polypeptides from fransicella tularensis
    Publication number: 20080108793
    Abstract: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 2. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
    Type: Application
    Filed: December 28, 2006
    Publication date: May 8, 2008
    Inventors: Judd M. Berman, Molly B. Schmid, Donald E. Awrey, Teresa Clarke McGrath, Bryan Beattie, Mandy Dorsey
  • Novel purified polypeptides from enterococcus faecalis
    Publication number: 20060003432
    Abstract: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
    Type: Application
    Filed: January 31, 2005
    Publication date: January 5, 2006
    Applicant: Affinium Pharmaceuticals, Inc.
    Inventors: Aled Edwards, Akil Dharamsi, Masoud Vedadi, Bryan Beattie, Teresa Clarke, Matthew Kimber
  • Peptidyl-tRNA hydrolase of Enterococcus faecalis
    Publication number: 20050239186
    Abstract: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
    Type: Application
    Filed: January 31, 2005
    Publication date: October 27, 2005
    Applicant: Affinium Pharmaceuticals, Inc.
    Inventors: Aled Edwards, Akil Dharamsi, Masoud Vedadi, Bryan Beattie, Matthew Kimber
  • Novel purified polypeptides from bacteria
    Publication number: 20050181388
    Abstract: The present invention relates to polypeptide targets for pathogenic bacteria. The invention also provides biochemical and biophysical characteristics of those polypeptides.
    Type: Application
    Filed: October 4, 2004
    Publication date: August 18, 2005
    Applicant: Affinium Pharmaceuticals, Inc.
    Inventors: Aled Edwards, Akil Dharamsi, Masoud Vedadi, Muhammad Alam, Cheryl Arrowsmith, Donald Awrey, Bryan Beattie, Kristina Buzadzija, Veronica Canadien, Megan Domagala, Simon Houston, Dhushy Kanagarajah, Qin Li, Kamran Mansoury, Merry-Lynn McDonald, Kathleen Nethery-Brokx, Ivy Ng, Hui Ouyang, Benjamin Pinder, Dawn Richards, Matthew Tai, Rosanne Thalakada, Francois Vallee, Cristina Virag
  • Novel purified polypeptides from bacteria
    Publication number: 20050181464
    Abstract: The present invention relates to polypeptide targets for pathogenic bacteria. The invention also provides biochemical and biophysical characteristics of those polypeptides.
    Type: Application
    Filed: September 29, 2004
    Publication date: August 18, 2005
    Applicant: Affinium Pharmaceuticals, Inc.
    Inventors: Aled Edwards, Akil Dharamsi, Masoud Vedadi, Muhammad Alam, Cheryl Arrowsmith, Donald Awrey, Bryan Beattie, Kristina Buzadzija, Teresa Clarke, Megan Domagala, Simon Houston, Dhushy Kanagarajah, Qin Li, Kamran Mansoury, Merry-Lynn McDonald, Kathleen Nethery-Brokx, Ivy Ng, Hui Ouyang, Dawn Richards, Francois Vallee, Cristina Virag
  • Novel purified polypeptides from pseudomonas aeruginosa
    Publication number: 20050164362
    Abstract: The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
    Type: Application
    Filed: June 21, 2004
    Publication date: July 28, 2005
    Applicant: Affinium Pharmaceuticals, Inc.
    Inventors: Aled Edwards, Akil Dharamsi, Masoud Vedadi, Muhammad Alam, Megan Domagala, Simon Houston, Matthew Kimber, Benjamin Pinder, Francois Vallee, Olga Wrezel, Donald Awrey, Bryan Beattie